Genoptix Reports Strong Financial Results for the Fourth Quarter and Full...(ome per share pursuant to the ter...),Health
Navigation Links
Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007
Date:2/12/2008
ome per share pursuant
to the terms of the preferred stock, resulting in $3,317 of net income
allocable to common stockholders. See Note 1 to the Notes to
Consolidated Financial Statements in the Annual Report on Form 10-K
for calculations of the pro forma net income (loss) per share for the
periods presented.
'/>"/>
| SOURCE Genoptix, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Genoptix, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 12, 2008
2. Genoptix, Inc. Announces Pricing for Initial Public Offering
3. MIB Life Index Reports North American Life Insurance Activity Up 1.4% in December
4. NxStage Medical Reports Fourth Quarter and Full Year 2007 Results
5. Nutrition 21 Reports Fiscal Second Quarter 2008 Financial Results
6. Mesa Labs Reports Higher Quarterly Sales and Earnings
7. Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007
8. Palatin Technologies, Inc. Reports Fiscal Year 2008 Second Quarter Results; Teleconference and Webcast to be held on February 11, 2008
9. LCA-Vision Reports Fourth Quarter and Full-Year 2007 Financial Results
10. Neurobiological Technologies Reports Second Quarter Financial Results
11. Hawkins, Inc. Reports Third Quarter, Nine Months Fiscal 2008 Results
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Doctors and Scientists Create New Society to Promote Non-Animal Toxicology Testing Methods 2Health News:Alcohol consumption may increase breast cancer recurrence risk 2Health News:Bad Behavior as a Kid Linked to Early Death in Men 2Health News:Northeast Chiropractic, PC Revolutionizes Pain Management Without Medication, Now Offering New and Unique Blend of Treatments 2
[0] Doctors and Scientists Create New Society to Promote Non-Animal Toxicology Testing Methods[0] Alcohol consumption may increase breast cancer recurrence risk[0] Newly discovered mechanism by which blood clots form[0] Bad Behavior as a Kid Linked to Early Death in Men[0] Northeast Chiropractic, PC Revolutionizes Pain Management Without Medication, Now Offering New and Unique Blend of Treatments
Other Medicine News:Health News:American Cancer Society report finds breast cancer death rate continues to drop 2Health News:American Cancer Society report finds breast cancer death rate continues to drop 3Health News:American Cancer Society report finds breast cancer death rate continues to drop 4Health News:Shop 'n Save Pharmacy Helps Vitalize Members of Wellness-based Health Insurance Plan 2Health News:Shop 'n Save Pharmacy Helps Vitalize Members of Wellness-based Health Insurance Plan 3Health News:Portico Systems Wins Three Awards in 30 Days 2Health News:Breast cancer susceptibility gene predicts outcome and response to treatment in lung cancer 2Health News:Breast cancer susceptibility gene predicts outcome and response to treatment in lung cancer 3Health News:Regular Eye Screens Spot Diabetic Vision Trouble 2Health News:Spectrum Pharmaceuticals to Present at the UBS Global Life Sciences Conference 2
American Cancer Society report finds breast cancer death rate continues to dropShop 'n Save Pharmacy Helps Vitalize Members of Wellness-based Health Insurance PlanPortico Systems Wins Three Awards in 30 DaysBreast cancer susceptibility gene predicts outcome and response to treatment in lung cancerRegular Eye Screens Spot Diabetic Vision TroubleSpectrum Pharmaceuticals to Present at the UBS Global Life Sciences Conference
Breaking Medicine Technology:OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 2Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 3Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lee's Pharmaceuticals 2Your own private global warming 9125 1Nano measurement in the third dimension 12903 1Nano measurement in the third dimension 12903 2New Evidence Supports HPV Vaccine 50832 1New Evidence Supports HPV Vaccine 50832 2
[0] OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months[0] Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution[0] Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lee's Pharmaceuticals
Other Medicine Technology:Hospitalization Rates for Coronary Artery Disease Decline in the,U.S. 2Hospitalization Rates for Coronary Artery Disease Decline in the,U.S. 3Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor,Data Showing Broad Anti-Tumor Activity, Dosing Flexibility 2Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor,Data Showing Broad Anti-Tumor Activity, Dosing Flexibility 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |